Influence of Placebo on Intratissue Percutaneous Electrolysis in Patellar Tendinopathy
Patellar Tendinopathy
About this trial
This is an interventional treatment trial for Patellar Tendinopathy
Eligibility Criteria
Inclusion Criteria:
- 18 years old or older
- presenting the following signs and symptoms of patellar tendinopathy: pain when jumping, landing, running o changing direction, pain at the inferior pole of the patella, Victorian Institute of Sport Assessment-Patella (VISA-P) score <80, symptoms duration of at least 3 months.
Exclusion Criteria:
- prior knee surgery
- patients having received local corticosteroids injection in the tendon within the preceding 6 months
- patients presenting any inflammatory disease, metabolic bone disease, type II diabetes, fibromyalgia, hypercholesterolemia, pregnancy or chemotherapy within the 3 months prior to the study.
Sites / Locations
- Mercè Balasch i BernatRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Placebo Comparator
Placebo Comparator
Placebo Comparator
Group E1: IPE applied, participants believe they are receiving IPE.
Group E2: IPE applied, participants believe they are receiving placebo.
Group P1: IPE not applied, participants believe they are receiving IPE.
Group P2: IPE not applied, participants believe they are receiving placebo.
IPE will be applied following the standard protocol for PT. Participants will believe they are receiving IPE.
IPE will be applied following the standard protocol for PT. Subjects will be led to believe that the intensity of the current is below the threshold necessary to cause changes in the tissue.
The needle will be inserted under the skin but the current will not be passing through. The subjects will see a shame video on the ultrasound screen so they will believe that the IPE is being performed.
The needle will be inserted under the skin, subjects will be led to believe that the intensity of the current is below the threshold necessary to cause changes in the tissue.